Despite a marginal positive shift at CEO level, overall representation of women in leadership positions in UK biotech have stalled according to the BioIndustry Association’s report, Women in Biotech ...

Reflecting on the Chancellor’s Spring Statement, it was clear that this was largely an opportunity to explain the direction of the economy; making the Government’s case as to why their plan is the ...

Cambridge2Cambridge transatlantic company Mursla Bio is building on its US presence with its nextgen liver cancer ...

Last year, the Government announced a cash injection of £102 million of capital funding for bricks and mortar upgrades within GP-based healthcare services. It’s a healthcare space in which BTG ...

Oxford Business Park company, Oxa, has revealed a successful first close of its Series D funding round, raising a total of $103 million. A second and final Series D close is expected in H1 2026.

Law firm Mills & Reeve advised on an over-subscribed seed extension investment round for Microneedle Solutions (MNS), which will enable the company to advance its Miracus™ needle-free patch platform ...

The Employment Rights Act 2025 will strengthen unfair dismissal protection for employees by reducing the length of service they need to bring an Employment Tribunal claim and removing the cap on ...

A new Google DeepMind Academic Fellowship is to be hosted at the Wellcome Sanger Institute in Cambridge, exploring the application of artificial intelligence (AI) in genomics through a ...

As anticipated, the Chancellor’s 2026 Spring Statement was a rather quiet affair on fiscal matters and the emphasis was very ...

AIM-listed specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has promoted ...

AIM-quoted Cambridge company, CyanConnode, a global provider of IoT communication and smart metering solutions, says it has ...

Arm has entered into a strategic partnership with Danantara Indonesia, the sovereign investment institution of the Republic ...